Immunosuppressive biologics did not increase the risk of COVID-19 or subsequent mortality: a retrospective matched cohort study from Massachusetts

Supplemental materials for the manuscript titled, "Immunosuppressive biologics did not increase the risk of COVID-19 or subsequent mortality: a retrospective matched cohort study from Massachusetts," published in the Journal of the American Academy of Dermatology.

Vartan Pahalyants MD, MBA1,2*, William S. Murphy MD, MBA1*, Nikolai Klebanov MD1, Chenyue Lu MBI1, Nicholas Theodosakis MD1, R. Monina Klevens DDS3, Hossein Estir PhD4,5, Evelyn Lilly MD1, Maryam Asgari MD1, Yevgeniy R. Semenov MD, MA1

1Massachusetts General Hospital, Department of Dermatology, Boston, MA
2Brigham and Women’s Hospital, Department of Medicine, Boston, MA
3Massachusetts Department of Public Health, Bureau of Infectious Disease and Laboratory Sciences, Boston, MA
4Laboratory of Computer Science, Massachusetts General Hospital, Boston, MA
5Department of Medicine, Massachusetts General Hospital, Boston, MA

* Designates co-first authors

The supplement includes detailed methods, the study flow diagram, as well as supplemental analyses not included in the published manuscript.

《免疫抑制生物制剂并未增加COVID-19感染风险或后续死亡率：来自马萨诸塞州的回顾性匹配队列研究》一文的补充材料，该研究发表于美国皮肤病学学会杂志。该补充材料包括详细的研究方法、研究流程图，以及未包含在已发表手稿中的补充分析。